AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • November 13th, 2009 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations
This Amendment No. 1 to Employment Agreement (this “Amendment”) is made as of the 14th day of September 2009, by and between ImmunoCellular Therapeutics, Ltd., a Delaware corporation (the “Corporation”), and Dr. James Bender (hereinafter called “Executive”).
SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 13th, 2009 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations
THIS SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (this “Amendment”) is made and entered into as of August 1, 2009 (“Effective Date”), by and between Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“CSMC”), and ImmunoCellular Therapeutics, Ltd., a Delaware corporation (“Licensee”), under the following circumstances:
